Literature DB >> 13680034

Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucoma.

Kivanc Güngör1, Mehtap Ozkur, Ingolf Cascorbi, Jürgen Brockmöller, Necdet Bekir, Ivar Roots, A Sükrü Aynacioglu.   

Abstract

OBJECTIVE: It has been shown that arginine to glycine (Arg16Gly), glutamine to glutamic acid (Gln27Glu) and threonine to isoleucine (Thr164Ile) exchanges in codons 16, 27 and 164, respectively, of the beta 2-adrenergic receptor (B2AR) gene significantly alter receptor function. As B2ARs are located on the afferent blood vessels supplying the ciliary body and trabecular meshwork cells, which control aqueous humour dynamics, polymorphisms of B2AR may be involved in the pathophysiology of certain eye diseases, such as glaucoma. Therefore, the aim of the present study was to investigate the distribution of B2AR polymorphisms in patients with primary congenital and primary open angle glaucoma.
METHODS: A group of 30 patients with primary congenital glaucoma, 105 with primary open angle glaucoma and 92 control patients were analysed for the Arg16Gly, Gln27Glu, and Thr164IIe polymorphisms of the B2AR by polymerase chain reaction-restriction fragment length polymorphism.
RESULTS: The allelic frequencies of Gly16, Glu27 and IIe164 variant alleles were 66.7, 38.3 and 3.3% in patients with congenital glaucoma, 59.5, 31.0 and 1.0% with glaucoma, and 54.9, 26.6 and 0.5% in controls, respectively. Although statistically non-significant, the frequencies of variant alleles were slightly higher in both groups of the glaucoma patients.
CONCLUSIONS: These results suggest no evidence of an association between the Arg16Gly, Glu27Gln and Thr164Ile polymorphisms of the B2AR gene and risk of developing primary open angle glaucoma or primary congenital glaucoma. However, further studies are needed to understand the role of B2AR polymorphisms in patients with eye disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680034     DOI: 10.1007/s00228-003-0658-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  32 in total

1.  GLC1F, a new primary open-angle glaucoma locus, maps to 7q35-q36.

Authors:  M K Wirtz; J R Samples; K Rust; J Lie; L Nordling; K Schilling; T S Acott; P L Kramer
Journal:  Arch Ophthalmol       Date:  1999-02

2.  Size of the physiologic cup of the optic nerve head. hereditary and environmental factors.

Authors:  J T Schwartz; F H Reuling; M Feinleib
Journal:  Arch Ophthalmol       Date:  1975-09

3.  A third locus (GLC1D) for adult-onset primary open-angle glaucoma maps to the 8q23 region.

Authors:  O C Trifan; E I Traboulsi; D Stoilova; I Alozie; R Nguyen; S Raja; M Sarfarazi
Journal:  Am J Ophthalmol       Date:  1998-07       Impact factor: 5.258

4.  Distribution and properties of beta-adrenergic receptors in human iris-ciliary body.

Authors:  M B Wax; P B Molinoff
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-03       Impact factor: 4.799

5.  The genetic determination of ocular pressure in the normal eye.

Authors:  M F Armaly
Journal:  Arch Ophthalmol       Date:  1967-08

6.  Polymorphisms of the beta2-adrenergic receptor and asthma.

Authors:  S B Liggett
Journal:  Am J Respir Crit Care Med       Date:  1997-10       Impact factor: 21.405

7.  Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.

Authors:  F D Martinez; P E Graves; M Baldini; S Solomon; R Erickson
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

8.  Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension.

Authors:  M S Bray; J Krushkal; L Li; R Ferrell; S Kardia; C F Sing; S T Turner; E Boerwinkle
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

9.  Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.

Authors:  J Turki; J Pak; S A Green; R J Martin; S B Liggett
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Mutations in MYOC gene of Indian primary open angle glaucoma patients.

Authors:  Arijit Mukhopadhyay; Moulinath Acharya; Saibal Mukherjee; Jharna Ray; Sumit Choudhury; Mita Khan; Kunal Ray
Journal:  Mol Vis       Date:  2002-11-15       Impact factor: 2.367

View more
  3 in total

1.  Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma.

Authors:  J H Kang; S J Loomis; B L Yaspan; J C Bailey; R N Weinreb; R K Lee; P R Lichter; D L Budenz; Y Liu; T Realini; D Gaasterland; T Gaasterland; D S Friedman; C A McCarty; S E Moroi; L Olson; J S Schuman; K Singh; D Vollrath; G Wollstein; D J Zack; M Brilliant; A J Sit; W G Christen; J Fingert; J P Forman; E S Buys; P Kraft; K Zhang; R R Allingham; M A Pericak-Vance; J E Richards; M A Hauser; J L Haines; J L Wiggs; L R Pasquale
Journal:  Eye (Lond)       Date:  2014-03-07       Impact factor: 3.775

2.  Progress toward personalized medicine for glaucoma.

Authors:  Sayoko E Moroi; Duna A Raoof; David M Reed; Sebastian Zöllner; Zhaohui Qin; Julia E Richards
Journal:  Expert Rev Ophthalmol       Date:  2009-04

Review 3.  Complex genetic mechanisms in glaucoma: an overview.

Authors:  Kollu N Rao; Srujana Nagireddy; Subhabrata Chakrabarti
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.